HF 4

  • Minnesota House Bill
  • 2019-2020 Regular Session
  • Introduced in House Jan 10, 2019
  • House
  • Senate
  • Governor

Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; civil penalties imposed; and money appropriated.

Abstract

Bill Sponsors (35)

Olson

     
Cosponsor

Lillie

     
Cosponsor

Carlson, A.

     
Cosponsor

Xiong, T.

     
Cosponsor

Votes


No votes to display

Actions


Mar 26, 2020

House

Committee report, without further rec to amend, re-refer to Ways and Means

Mar 11, 2020

House

Committee report, without further rec to amend, re-refer to State Government Finance Division

Feb 27, 2020

House

Division action, to adopt as amended and return to Ways and Means

Apr 03, 2019

House

Motion to recall and re-refer, motion did not prevail State Government Finance Division

Mar 04, 2019

House

Referred by Chair to Health and Human Services Finance Division

House

Committee report, to adopt and re-refer to Ways and Means

Feb 21, 2019

House

Committee report, to adopt as amended and re-refer to Judiciary Finance and Civil Law Division

Feb 07, 2019

House

Committee report, to adopt as amended and re-refer to Commerce

Jan 14, 2019

House

Author added Mariani

Jan 10, 2019

House

Introduction and first reading, referred to Health and Human Services Policy

Bill Text

Bill Text Versions Format
Introduction HTML
1st Engrossment HTML
2nd Engrossment HTML
3rd Engrossment HTML
4th Engrossment HTML
1st Division Engrossment HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Minnesota Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.